Is there justification for universal leukoreduction?
Main Authors: | Alfredo Mendrone Jr., Antonio Fabron Jr., Dante Langhi Jr., Dimas Tadeu Covas, Carla Luana Dinardo, Eugênia Amorim Ubiali, José Francisco Comenalli Marques Jr., José Orlando Bordin, Marilia Rugani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-07-01
|
Series: | Revista Brasileira de Hematologia e Hemoterapia |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842014000400237&lng=en&tlng=en |
Similar Items
-
Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19
by: Gil Cunha De Santis, et al.
Published: (2021-04-01) -
Why implement universal leukoreduction?
by: Wafaa Y. Bassuni, et al.
Published: (2008-04-01) -
Guidelines on Beta-thalassemia major - regular blood transfusion therapy: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associação Médica Brasileira - 2016
by: Dante Langhi Jr, et al. -
Effect Evaluation of Leukoreduction Filters on Canine Whole Blood
by: Wang, Chi-Ya, et al.
Published: (2018) -
Leukoreduction and hydroxyurea in malignant pertussis: A case series
by: Nedaa Aldairi, et al.
Published: (2020-12-01)